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Otto Warburg fi  rst described that cancer cells exhibit altered 
cellular glucose metabolism that relies primarily on glycolysis 
rather than mitochondrial respiration in 1930 (Warburg, 1930, 
1956). This observation, termed the “Warburg effect,” was 
largely set aside as modern research techniques evolved, and 
only in recent years has it seen a renaissance in both the clinic 
and the laboratory. In the clinic, positron emission tomography 
imaging using labeled glucose tracers takes advantage of cancer 
cells’ increased glucose uptake to image tumors in human 
patients. In the laboratory, researchers have been attempting to 
piece together whether the switch from mitochondrial respiration 
to glycolysis could fi  t with the survival advantages observed in 
cancers. Despite the obvious benefi  ts of anaerobic metabolism 
in areas of tissue hypoxia, the signifi  cantly lower energy yield 
per glucose molecule would appear to be generally detrimental. 
Nevertheless, increased glycolysis may have other positive 
effects that outweigh the negative. In this issue, Pelicano et al. 
(see p. 913 of this issue) describe one mechanism by which loss 
of mitochondrial respiration may provide a survival advantage 
by activating the phosphatidylinositol 3-kinase (PI3K)–Akt 
 survival  pathway.
Mitochondrial respiration is often disrupted in cancer 
because of hypoxia or debilitating mutations in the mitochon-
drial DNA (mtDNA) that impede electron transport. To investi-
gate the possible role that these respiration defi  ciencies play in 
enhancing cell survival, Pelicano et al. disrupted mitochondrial 
respiration by genetic (mtDNA mutation), pharmacological 
(chemical inhibition), and microenvironmental (hypoxia) meth-
ods in human leukemia and lymphoma cell lines. Although 
these forms of metabolic disruption did not greatly alter the 
characteristics of the mitochondria, they did provide a survival 
advantage for the cells upon treatment with several common 
anticancer agents. In searching for a possible explanation for 
this survival phenotype, they observed increased levels of 
activating Akt phosphorylation in respiration-defi  cient  cells. 
Enhanced phosphorylation of the Akt substrate glycogen syn-
thase kinase-3 supported the conclusion that decreased mito-
chondrial respiration led to increased activity of the PI3K–Akt 
pathway. The authors go on to argue that increased NADH lev-
els, which were caused by defective consumption of NADH in 
mitochondria, and decreased NADPH levels, which were caused 
by increased fl  ux of glucose through glycolysis at the expense 
of the pentose phosphate pathway (PPP), led to oxidation of 
the tumor suppressor PTEN, a lipid phosphatase that negatively 
regulates the PI3K pathway. An inhibitor of PI3K signaling, 
along with PTEN-null cell lines, was then used to support their 
conclusion that the enhanced survival phenotype of respiration-
defi  cient cells is caused by enhanced PI3K–Akt activation.
The role of the PI3K–Akt pathway in cancer has been 
intensely investigated and has been shown to play roles in cell 
survival, growth, cell cycle entry, and cell migration—all of 
which are key characteristics of cancer cells. Indeed, this 
pathway has been shown to be hyperactivated in many cancers, 
often by genetic mutation of PTEN, or by activation of onco-
genic signaling proteins such as Ras (for review see Cully et al., 
2006). Mutations of PI3K–Akt–regulating genes may not, 
however, fully explain the observed activation of this pathway. 
It is tempting to speculate that loss of respiration may be 
responsible for some PI3K–Akt activation observed in cancer 
cells, as the large majority of tumors display this metabolic phe-
notype. Importantly, activation of Akt may also play a key role 
in up-regulating glucose uptake and glycolysis to support the 
viability and growth of respiration-defi  cient cells (Plas et al., 
2001; Rathmell et al., 2003). This may represent a feed-forward 
mechanism of loss of mitochondrial respiration, accumulation 
of NADH, activation of Akt, and increased glucose uptake 
to thus complete a switch to glycolysis as the primary cellular 
ATP source.
It is becoming clear that metabolites can play critical 
roles in cell signaling pathways (Ladurner, 2006), and the 
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NADH/NADPH ratio may be one new example. In addition to 
this example of metabolite-based regulation of cell survival, 
glucose fl  ux through the PPP has also been shown recently to 
play critical roles in cell survival in other systems. Nutt et al. 
(2005) have shown that PPP substrates and intermediates can 
act as a metabolic timer for the initiation of apoptosis in the 
Xenopus laevis oocyte extract system. Normally, X. laevis egg 
extracts undergo a spontaneous process resembling apoptosis 
after several hours. Addition of PPP intermediates or NADPH, 
however, prevented this apoptosis. Mechanistically, NADPH 
appeared to promote CaMKII-mediated phosphorylation of 
  caspase-2 to prevent its ability to initiate mitochondrial 
disruption, release of cytochrome c, and activation of caspase 3. 
Additionally, Bensaad et al. (2006) have identifi   ed a novel 
antiapoptotic protein, TP53-induced glycolysis and apoptosis 
regulator (TIGAR), which is induced by p53 under low levels 
of stress and functions to shunt additional glucose away from 
glycolysis toward the PPP to promote cell viability. These 
studies exemplify the importance of the PPP in protecting cells 
from stress and suggest that the effects of PPP modulation may 
be context dependent. It will be very interesting to see the results 
as studies further defi  ne mechanisms that regulate glucose fl  ux 
through the PPP and the role this plays in survival of cancer 
cells under a variety of physiological and drug-induced stress.
In addition to the regulation of NADH and NADPH, 
changes in many aspects of cell metabolism can impact 
mitochondria, and these organelles are becoming increasingly 
apparent as sensors of metabolic stress that possess the capacity 
to signal this stress to the cytosol and nucleus (Fig. 1). The 
Avandhani group has published a series of papers showing that 
mtDNA mutation can raise intracellular Ca
2+ levels and affect a 
variety of Ca
2+-dependent pathways. Mitochondrial stress led 
to activation of the Ca
2+- and calmodulin-dependent phosphatase 
calcineurin, JNK pathways, inactivation of NF-κB, induction of 
antiapoptotic Bcl-2 family members Bcl-2 and Bcl-xL, and 
repression of proapoptotic family members Bid and Bax (Biswas 
et al., 2005). In addition, mitochondrial generation of reactive 
oxygen species can play a substantial role in cell physiology, 
and has recently been shown to be required to allow stabiliza-
tion of the hypoxia inducible factor-1α transcription factor 
under hypoxic conditions (Brunelle et al., 2005). These examples 
of metabolic machinery talking to the rest of the cell through 
existing signaling pathways display the importance of metabolic 
processes on an entirely different level than simply serving as a 
cellular energy source.
Although the Warburg effect is well documented and 
universally accepted, its effect on tumor biology has remained 
elusive. By artifi  cially reproducing this effect in the absence of 
other major oncogenic events, we are beginning to appreciate 
how cancer cells not only survive this metabolic shift, but how 
it may allow them to thrive in stressful conditions via activation 
of survival pathways, such as Akt. Understanding the metabolic 
phenotype of cancer cells and its effects on cell signaling 
mechanisms not only affords us a better understanding of tumor 
biology, but may present a plethora of potential targets for 
advanced cancer therapies.
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